Fetal Monitoring Market - Global Outlook & Forecast 2024-2029

Fetal Monitoring Market - Global Outlook & Forecast 2024-2029


The global fetal monitoring market is expected to grow at a CAGR of 7.74% from 2023 to 2029.

The market is experiencing dynamic growth, driven by technological advancements, increasing awareness of prenatal care, and rising incidences of high-risk pregnancies. As the market evolves, several key premium insights provide a deeper understanding of its current and future trajectory. Continuous technology innovation is one of the most significant drivers of the fetal monitoring market. Recent advancements have led to developing more sophisticated and user-friendly monitoring devices. Moreover, the shift towards non-invasive monitoring techniques is another critical trend in the market. Non-invasive methods, such as Doppler ultrasound and external fetal monitoring, are preferred by both patients and healthcare providers due to their safety, comfort, and ease of use. These methods reduce the risk of complications associated with invasive procedures and are particularly important in cases requiring frequent monitoring.

MARKET TRENDS & DRIVERS

Integration of AI & ML in Fetal Monitoring

Integrating AI and ML in fetal monitoring opens new opportunities and sets transformative trends in the global market. These technologies enhance the accuracy, efficiency, and accessibility of prenatal care, leading to better outcomes for mothers and babies. For instance, AI and ML facilitate personalized prenatal care by analyzing patient data to tailor monitoring and treatment plans. Personalized care improves patient outcomes by addressing each patient's specific needs and risks. For instance, AI can recommend customized monitoring schedules based on a mother’s medical history and current health status. As AI and ML continue to evolve, they promise to revolutionize fetal monitoring further, making it more predictive, personalized, and proactive.

Growing Significance of Remote Fetal Monitoring

Remote fetal monitoring is revolutionizing prenatal care by providing accessible, convenient, and continuous monitoring of fetal health. The growing significance of these technologies is evident in their ability to enhance maternal and fetal outcomes, empower expectant mothers, and reduce healthcare disparities. The global fetal monitoring market is poised for significant growth, driven by the expansion of telehealth services, advancements in wearable devices, and the integration of big data and AI. Moreover, integrating big data and AI in remote fetal monitoring presents significant opportunities for predictive analytics and personalized care.

Manufacturers Focus on Developing Portable, Wireless, and Advanced Fetal Monitors

The focus on developing portable, wireless, and advanced fetal monitors has significantly shaped the global fetal monitoring market. These innovations offer numerous benefits, including enhanced mobility, improved comfort, and better integration with telemedicine platforms. Adopting advanced features such as AI, data analytics, and non-invasive monitoring techniques further drives market growth. As the demand for remote monitoring and comprehensive prenatal care continues to rise, manufacturers are well-positioned to capitalize on these opportunities, ultimately improving maternal and fetal health outcomes worldwide.

Growing Awareness and Demand for Prenatal Care

The growing awareness and demand for prenatal care drive the global fetal monitoring market. Factors such as rising awareness of prenatal health, technological advancements, the increasing prevalence of high-risk pregnancies, government initiatives, and the growing demand for home-based monitoring solutions contribute to the market's expansion. As expectant parents and healthcare providers continue to prioritize the health and well-being of the mother and fetus, the demand for advanced and reliable fetal monitoring systems is expected to remain robust, fueling further growth in the market.

Rising Number of Preterm Births & Increasing Adoption of Infertility Treatment

The rising number of preterm births and the increasing adoption of infertility treatments are significant drivers of the global fetal monitoring market. The demand for advanced, reliable, and efficient fetal monitoring systems will grow more during the forecast period. Technological advancements and supportive healthcare policies will be crucial in meeting this demand and ensuring better health outcomes for mothers and their babies. The future of fetal monitoring looks promising, with continuous innovations set to enhance prenatal care and address the challenges posed by high-risk pregnancies.

New Product Launches

The continuous launch of new and innovative products is dynamically shaping the global fetal monitoring market. Technological advancements, regulatory approvals, strategic collaborations, and a focus on enhancing patient experience drive the market forward. As these new products address evolving clinical needs and improve accessibility to advanced monitoring solutions, they are poised to significantly impact maternal and fetal health outcomes worldwide. The future of fetal monitoring looks promising, with ongoing innovation paving the way for safer, more efficient, and more comprehensive care for expectant mothers and their babies.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT TYPE

The global fetal monitoring market by product type is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal Doppler, uterine contraction monitors, and telemetry devices. The ultrasound devices segment holds the most significant global market share in 2023. Ultrasound devices are one of the most commonly used tools in fetal monitoring. These devices utilize high-frequency sound waves to create images of the fetus inside the womb, allowing healthcare providers to assess fetal development, check for abnormalities, and monitor the fetus’s growth and position. Furthermore, one of the most significant advancements in ultrasound technology is the development of 3D and 4D ultrasound. While traditional 2D ultrasound provides flat, two-dimensional images, 3D ultrasound generates three-dimensional images, offering a more detailed view of the fetus. 4D ultrasound adds dimension to time by creating real-time video images of fetal movements. These technologies allow for more detailed assessments of fetal anatomy and can enhance the detection of congenital anomalies.

Segmentation by Product Type
  • Ultrasound Devices
  • Electronic Maternal/Fetal Monitors
  • Fetal Electrodes
  • Fetal Doppler
  • Uterine Contraction Monitors
  • Telemetry Devices
  • Others
INSIGHTS BY PORTABILITY

Portable portability holds the most significant share of the global fetal monitoring market 2023. Portable fetal monitoring devices are compact, lightweight, and designed for mobility, allowing them to be used in various settings, including hospitals, clinics, home-care environments, and even during patient transport. Portable devices enable healthcare providers to monitor fetal well-being in diverse environments, including remote or underserved areas where access to healthcare facilities may be limited. With the increasing emphasis on patient-centered care, portable devices facilitate monitoring in home-care settings, allowing expectant mothers to undergo routine checks without frequent hospital visits.

Segmentation by Portability
  • Portable
  • Non-Portable
INSIGHTS BY METHOD

The global fetal monitoring market by method is segmented into non-invasive and invasive. The non-invasive segment holds the largest market share in 2023. Non-invasive methods include ultrasound, external fetal monitoring, and fetal Doppler. These methods are generally preferred for routine monitoring due to their safety, ease of use, and ability to provide real-time data without direct contact with the fetus. Moreover, non-invasive fetal monitoring eliminates the risks associated with invasive procedures, such as infections, bleeding, or injury to the fetus. This makes it a safer option for the mother and the baby, particularly in routine monitoring or low-risk pregnancies. Furthermore, invasive methods include internal fetal monitoring and fetal scalp blood sampling. These techniques are used when more accurate and detailed information is needed, particularly in high-risk pregnancies or labor scenarios where non-invasive methods may be insufficient.

Segmentation by Method
  • Non-Invasive
  • Invasive
INSIGHTS BY APPLICATION

The antepartum application holds the largest share of the global fetal monitoring market. Antepartum fetal monitoring refers to assessing fetal well-being before the onset of labor. This type of monitoring aims to identify any potential issues that could affect the fetus and allows for early intervention to prevent complications. And intrapartum fetal monitoring refers to assessing fetal well-being during labor and delivery. This monitoring is crucial for detecting signs of fetal distress or complications that may arise during the birthing process. Furthermore, the choice of monitoring techniques and methods depends on the clinical situation, the risk level of the pregnancy, and the healthcare provider's judgment. Together, these monitoring strategies improve maternal and fetal outcomes by allowing timely interventions and informed decision-making throughout the pregnancy and delivery.

Segmentation by Application
  • Antepartum
  • Intrapartum
INSIGHTS BY END-USER

The global fetal monitoring market by end-user is segmented into hospitals, obstetrics & gynecology clinics, and others. In 2023, hospitals held the most extensive segmental share. Hospitals are the primary end-users of fetal monitoring systems, particularly during labor and delivery. They are equipped with the most advanced and comprehensive fetal monitoring technologies, designed to handle a wide range of situations, from routine monitoring to high-risk pregnancies. Hospitals typically have access to the latest and most sophisticated fetal monitoring equipment, including external and internal monitors. They may also use additional technologies such as ultrasound machines, central monitoring systems, and integrated patient management systems to store and analyze data in real time.

Furthermore, OB-GYN clinics frequently perform routine fetal monitoring during prenatal visits to check the fetal heart rate and overall well-being. Doppler ultrasound devices are commonly used for these purposes, offering a non-invasive way to monitor the fetus's health. Clinics often provide a more personalized and patient-centered approach to fetal monitoring. The settings are generally less clinical than hospitals, offering a more comfortable environment for expectant mothers. Also, fetal monitoring is increasingly used in other settings such as home care, imaging centers, and fertility centers. Each of these environments offers unique applications for fetal monitoring.

Segmentation by End-user
  • Hospitals
  • Obstetrics & Gynecology Clinics
  • Others
GEOGRAPHICAL ANALYSIS

The global fetal monitoring market is geographically diverse, with varying levels of market penetration, adoption of technology, and growth potential across different regions. The market dynamics are shaped by factors such as healthcare infrastructure, economic development, awareness of prenatal care, regulatory environments, and the prevalence of high-risk pregnancies. North America, particularly the U.S., is one of the largest and most mature markets for fetal monitoring. The region benefits from advanced healthcare infrastructure, high awareness of prenatal care, and significant investments in medical technology. North America held over 46% of the global fetal monitoring market share and dominated the global market in 2023.

Europe is another significant fetal monitoring market, with well-established healthcare systems and a strong focus on maternal and child health. The market is characterized by high adoption rates of advanced fetal monitoring technologies, particularly in Western Europe. The European market has evolved significantly, driven by technological advancements, growing maternal and fetal health awareness, and supportive healthcare policies. Furthermore, the APAC fetal monitoring market is rapidly growing, driven by large populations, increasing healthcare expenditures, and improving healthcare infrastructure in many countries. Also, Latin America, Middle East & Africa are emerging in the global fetal monitoring market, with countries like Brazil, Mexico, and Argentina leading. The region is experiencing growth in healthcare infrastructure and increasing awareness of prenatal care. While growth potential exists in urban and economically developed areas, rural regions face substantial challenges.

Segmentation by Geography
  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • The U.K.
  • Italy
  • Spain
  • Russia
  • Netherlands
  • APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa
  • UAE
COMPETITIVE LANDSCAPE

The global fetal monitoring market is characterized by intense competition among players, including established multinational corporations, emerging companies, and local firms. This competition is driven by the need to innovate, the increasing demand for advanced maternal and fetal health solutions, and the continuous push to expand market share across different regions. Some of the key players in the global fetal monitoring market are Cardinal Health, CONTEC MEDICAL SYSTEMS, GE Healthcare, Koninklijke Philips, and Siemens Healthineers.

Further, companies in the global fetal monitoring market employ various competitive strategies to maintain and expand their market positions. These strategies include product innovation, strategic partnerships and acquisitions, geographic expansion, and competitive pricing. For instance, mergers and acquisitions and strategic partnerships are common strategies in the market, enabling companies to expand their product portfolios, enter new markets, and gain access to new technologies. Players like GE Healthcare have engaged in strategic acquisitions to strengthen their market positions. By acquiring smaller companies with innovative technologies, these giants can quickly integrate new products into their portfolios and expand their customer base.

Key Company Profiles
  • Cardinal Health
  • CONTEC MEDICAL SYSTEMS
  • GE Healthcare
  • Koninklijke Philips
  • Siemens Healthineers
Other Prominent Vendors
  • Advanced Instrumentations
  • Atom Medical
  • Biolight Healthcare
  • Bistos
  • BPL Medical Technologies
  • BRAEL
  • ChoiceMMed
  • EDAN Instruments
  • France Création & Comed
  • General Meditech
  • Gima S.p.A.
  • Greatmade Tech
  • Huntleigh Healthcare
  • JUMPER
  • MEDGYN PRODUCTS
  • Medi Waves
  • MEDIANA
  • medical Econet
  • Meditech Equipment
  • Moretti S.p.A.
  • Narang Medical
  • Newman Medical
  • Promed Technology
  • PROMISE TECHNOLOGY
  • Shenzhen Aeon Technology
  • Shenzhen Bestman Instrument
  • Shenzhen Luckcome Technology
  • SHENZHEN UNICARE ELECTRONIC
  • Spengler Holtex Group
  • Surgitek
  • Technocare Medisystems
  • The Cooper Companies
  • TOITU
  • TRISMED
  • Ultrasound Technologies
  • YONKER
  • Zhengzhou Dison Instrument and Meter Co.
KEY QUESTIONS ANSWERED:

1. What is the growth rate of the global fetal monitoring market?

2. How big is the global fetal monitoring market?

3. Which region dominates the global fetal monitoring market share?

4. What are the significant trends in the fetal monitoring market?

5. Who are the key players in the global fetal monitoring market?


1. SCOPE & COVERAGE
1.1. MARKET DEFINITION
1.1.1. INCLUSIONS
1.1.2. EXCLUSIONS
1.1.3. MARKET ESTIMATION CAVEATS
1.2. SEGMENTS COVERED & DEFINITION
1.2.1. MARKET SEGMENTATION BY PRODUCT TYPE
1.2.2. MARKET SEGMENTATION BY PORTABILITY
1.2.3. MARKET SEGMENTATION BY METHOD
1.2.4. MARKET SEGMENTATION BY APPLICATION
1.2.5. MARKET SEGMENTATION BY END-USER
1.2.6. REGIONS & COUNTRIES COVERED
1.3. MARKET DERIVATION
1.3.1. HISTORIC, BASE, & FORECAST YEARS
2. PREMIUM INSIGHTS
2.1. OPPORTUNITY POCKETS
2.2. OVERVIEW
2.2.1. MARKET DYNAMICS
2.2.2. GEOGRAPHY INSIGHTS
2.2.3. PRODUCT TYPE INSIGHTS
2.2.4. PORTABILITY INSIGHTS
2.2.5. METHOD INSIGHTS
2.2.6. APPLICATION INSIGHTS
2.2.7. END-USER INSIGHTS
3. MARKET AT A GLANCE
4. INTRODUCTION
4.1. OVERVIEW
5. MARKET OPPORTUNITIES & TRENDS
5.1. INTEGRATION OF AI & ML IN FETAL MONITORING
5.2. GROWTH IN SIGNIFICANCE OF REMOTE FETAL MONITORING
5.3. GROWTH IN GOVERNMENT INITIATIVES & COLLABORATIONS FOR RESEARCH BY HEALTH AGENCIES
5.4. MANUFACTURERS FOCUS ON DEVELOPING PORTABLE, WIRELESS, AND ADVANCED FETAL MONITORS
6. MARKET GROWTH ENABLERS
6.1. GROWTH IN AWARENESS AND DEMAND FOR PRENATAL CARE
6.2. GROWTH IN ADVANCES & INNOVATIONS IN FETAL MONITORING TECHNOLOGIES
6.3. RISE IN NUMBER OF PRETERM BIRTHS & ADOPTION OF INFERTILITY TREATMENT
6.4. NEW PRODUCT LAUNCHES
7. MARKET RESTRAINTS
7.1. COMMON ERRORS IN FETAL HEART MONITORING
7.2. HIGH COST OF FETAL MONITORING EQUIPMENT
7.3. AVAILABILITY OF REFURBISHED EQUIPMENT
8. MARKET LANDSCAPE
8.1. MARKET OVERVIEW
8.2. MARKET SIZE & FORECAST
8.3. FIVE FORCES ANALYSIS
8.3.1. THREAT OF NEW ENTRANTS
8.3.2. BARGAINING POWER OF SUPPLIERS
8.3.3. BARGAINING POWER OF BUYERS
8.3.4. THREAT OF SUBSTITUTES
8.3.5. COMPETITIVE RIVALRY
9. PRODUCT TYPE
9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. ULTRASOUND DEVICES
9.3.1. MARKET OVERVIEW
9.3.2. MARKET SIZE & FORECAST
9.3.3. MARKET BY GEOGRAPHY
9.4. ELECTRONIC MATERNAL/FETAL MONITORS
9.4.1. MARKET OVERVIEW
9.4.2. MARKET SIZE & FORECAST
9.4.3. MARKET BY GEOGRAPHY
9.5. FETAL ELECTRODES
9.5.1. MARKET OVERVIEW
9.5.2. MARKET SIZE & FORECAST
9.5.3. MARKET BY GEOGRAPHY
9.6. FETAL DOPPLER
9.6.1. MARKET OVERVIEW
9.6.2. MARKET SIZE & FORECAST
9.6.3. MARKET BY GEOGRAPHY
9.7. UTERINE CONTRACTION MONITORS
9.7.1. MARKET OVERVIEW
9.7.2. MARKET SIZE & FORECAST
9.7.3. MARKET BY GEOGRAPHY
9.8. TELEMETRY DEVICES
9.8.1. MARKET OVERVIEW
9.8.2. MARKET SIZE & FORECAST
9.8.3. MARKET BY GEOGRAPHY
9.9. OTHERS
9.9.1. MARKET OVERVIEW
9.9.2. MARKET SIZE & FORECAST
9.9.3. MARKET BY GEOGRAPHY
10. PORTABILITY
10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. PORTABLE
10.3.1. MARKET OVERVIEW
10.3.2. MARKET SIZE & FORECAST
10.3.3. MARKET BY GEOGRAPHY
10.4. NON-PORTABLE
10.4.1. MARKET OVERVIEW
10.4.2. MARKET SIZE & FORECAST
10.4.3. MARKET BY GEOGRAPHY
11. METHOD
11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. NON-INVASIVE
11.3.1. MARKET OVERVIEW
11.3.2. MARKET SIZE & FORECAST
11.3.3. MARKET BY GEOGRAPHY
11.4. INVASIVE
11.4.1. MARKET OVERVIEW
11.4.2. MARKET SIZE & FORECAST
11.4.3. MARKET BY GEOGRAPHY
12. APPLICATION
12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. MARKET OVERVIEW
12.3. ANTEPARTUM
12.3.1. MARKET OVERVIEW
12.3.2. MARKET SIZE & FORECAST
12.3.3. MARKET BY GEOGRAPHY
12.4. INTRAPARTUM
12.4.1. MARKET OVERVIEW
12.4.2. MARKET SIZE & FORECAST
12.4.3. MARKET BY GEOGRAPHY
13. END-USER
13.1. MARKET SNAPSHOT & GROWTH ENGINE
13.2. MARKET OVERVIEW
13.3. HOSPITALS
13.3.1. MARKET OVERVIEW
13.3.2. MARKET SIZE & FORECAST
13.3.3. MARKET BY GEOGRAPHY
13.4. OBSTETRICS & GYNECOLOGY CLINICS
13.4.1. MARKET OVERVIEW
13.4.2. MARKET SIZE & FORECAST
13.4.3. MARKET BY GEOGRAPHY
13.5. OTHERS
13.5.1. MARKET OVERVIEW
13.5.2. MARKET SIZE & FORECAST
13.5.3. MARKET BY GEOGRAPHY
14. GEOGRAPHY
14.1. MARKET SNAPSHOT & GROWTH ENGINE
14.2. GEOGRAPHIC OVERVIEW
15. NORTH AMERICA
15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
15.2.1. PRODUCT TYPE
15.2.2. PORTABILITY
15.2.3. METHOD
15.2.4. APPLICATION
15.2.5. END-USER
15.3. KEY COUNTRIES
15.3.1. US: MARKET SIZE & FORECAST
15.3.2. CANADA: MARKET SIZE & FORECAST
16. EUROPE
16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
16.2.1. PRODUCT TYPE
16.2.2. PORTABILITY
16.2.3. METHOD
16.2.4. APPLICATION
16.2.5. END-USER
16.3. KEY COUNTRIES
16.3.1. GERMANY: MARKET SIZE & FORECAST
16.3.2. FRANCE: MARKET SIZE & FORECAST
16.3.3. UK: MARKET SIZE & FORECAST
16.3.4. ITALY: MARKET SIZE & FORECAST
16.3.5. SPAIN: MARKET SIZE & FORECAST
16.3.6. RUSSIA: MARKET SIZE & FORECAST
16.3.7. NETHERLANDS: MARKET SIZE & FORECAST
17. APAC
17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
17.2.1. PRODUCT TYPE
17.2.2. PORTABILITY
17.2.3. METHOD
17.2.4. APPLICATION
17.2.5. END-USER
17.3. KEY COUNTRIES
17.3.1. CHINA: MARKET SIZE & FORECAST
17.3.2. JAPAN: MARKET SIZE & FORECAST
17.3.3. INDIA: MARKET SIZE & FORECAST
17.3.4. SOUTH KOREA: MARKET SIZE & FORECAST
17.3.5. AUSTRALIA: MARKET SIZE & FORECAST
18. LATIN AMERICA
18.1. MARKET OVERVIEW
18.2. MARKET SIZE & FORECAST
18.2.1. PRODUCT TYPE
18.2.2. PORTABILITY
18.2.3. METHOD
18.2.4. APPLICATION
18.2.5. END-USER
18.3. KEY COUNTRIES
18.3.1. BRAZIL: MARKET SIZE & FORECAST
18.3.2. MEXICO: MARKET SIZE & FORECAST
18.3.3. ARGENTINA: MARKET SIZE & FORECAST
18.3.4. COLOMBIA: MARKET SIZE & FORECAST
19. MIDDLE EAST & AFRICA
19.1. MARKET OVERVIEW
19.2. MARKET SIZE & FORECAST
19.2.1. PRODUCT TYPE
19.2.2. PORTABILITY
19.2.3. METHOD
19.2.4. APPLICATION
19.2.5. END-USER
19.3. KEY COUNTRIES
19.3.1. TURKEY: MARKET SIZE & FORECAST
19.3.2. SAUDI ARABIA: MARKET SIZE & FORECAST
19.3.3. SOUTH AFRICA: MARKET SIZE & FORECAST
19.3.4. UAE: MARKET SIZE & FORECAST
20. COMPETITIVE LANDSCAPE
20.1. COMPETITION OVERVIEW
20.2. MARKET SHARE ANALYSIS
20.2.1. CARDINAL HEALTH
20.2.2. CONTEC MEDICAL SYSTEMS
20.2.3. GE HEALTHCARE
20.2.4. KONINKLIJKE PHILIPS
20.2.5. SIEMENS HEALTHINEERS
21. KEY COMPANY PROFILES
21.1. CARDINAL HEALTH
21.1.1. BUSINESS OVERVIEW
21.1.2. PRODUCT OFFERINGS
21.1.3. KEY STRATEGIES
21.1.4. KEY STRENGTHS
21.1.5. KEY OPPORTUNITIES
21.2. CONTEC MEDICAL SYSTEMS
21.2.1. BUSINESS OVERVIEW
21.2.2. PRODUCT OFFERINGS
21.2.3. KEY STRATEGIES
21.2.4. KEY STRENGTHS
21.2.5. KEY OPPORTUNITIES
21.3. GE HEALTHCARE
21.3.1. BUSINESS OVERVIEW
21.3.2. PRODUCT OFFERINGS
21.3.3. KEY STRATEGIES
21.3.4. KEY STRENGTHS
21.3.5. KEY OPPORTUNITIES
21.4. KONINKLIJKE PHILIPS
21.4.1. BUSINESS OVERVIEW
21.4.2. PRODUCT OFFERINGS
21.4.3. KEY STRATEGIES
21.4.4. KEY STRENGTHS
21.4.5. KEY OPPORTUNITIES
21.5. SIEMENS HEALTHINEERS
21.5.1. BUSINESS OVERVIEW
21.5.2. PRODUCT OFFERINGS
21.5.3. KEY STRATEGIES
21.5.4. KEY STRENGTHS
21.5.5. KEY OPPORTUNITIES
22. OTHER PROMINENT VENDORS
22.1. ADVANCED INSTRUMENTATIONS
22.1.1. BUSINESS OVERVIEW
22.1.2. PRODUCT OFFERINGS
22.2. ATOM MEDICAL
22.2.1. BUSINESS OVERVIEW
22.2.2. PRODUCT OFFERINGS
22.3. BIOLIGHT HEALTHCARE
22.3.1. BUSINESS OVERVIEW
22.3.2. PRODUCT OFFERINGS
22.4. BISTOS
22.4.1. BUSINESS OVERVIEW
22.4.2. PRODUCT OFFERINGS
22.5. BPL MEDICAL TECHNOLOGIES
22.5.1. BUSINESS OVERVIEW
22.5.2. PRODUCT OFFERINGS
22.6. BRAEL
22.6.1. BUSINESS OVERVIEW
22.6.2. PRODUCT OFFERINGS
22.7. CHOICEMMED
22.7.1. BUSINESS OVERVIEW
22.7.2. PRODUCT OFFERINGS
22.8. EDAN INSTRUMENTS
22.8.1. BUSINESS OVERVIEW
22.8.2. PRODUCT OFFERINGS
22.9. FRANCE CRÉATION & COMED
22.9.1. BUSINESS OVERVIEW
22.9.2. PRODUCT OFFERINGS
22.10. GENERAL MEDITECH
22.10.1. BUSINESS OVERVIEW
22.10.2. PRODUCT OFFERINGS
22.11. GIMA S.P.A.
22.11.1. BUSINESS OVERVIEW
22.11.2. PRODUCT OFFERINGS
22.12. GREATMADE TECH
22.12.1. BUSINESS OVERVIEW
22.12.2. PRODUCT OFFERINGS
22.13. HUNTLEIGH HEALTHCARE
22.13.1. BUSINESS OVERVIEW
22.13.2. PRODUCT OFFERINGS
22.14. JUMPER
22.14.1. BUSINESS OVERVIEW
22.14.2. PRODUCT OFFERINGS
22.15. MEDGYN PRODUCTS
22.15.1. BUSINESS OVERVIEW
22.15.2. PRODUCT OFFERINGS
22.16. MEDI WAVES
22.16.1. BUSINESS OVERVIEW
22.16.2. PRODUCT OFFERINGS
22.17. MEDIANA
22.17.1. BUSINESS OVERVIEW
22.17.2. PRODUCT OFFERINGS
22.18. MEDICAL ECONET
22.18.1. BUSINESS OVERVIEW
22.18.2. PRODUCT OFFERINGS
22.19. MEDITECH EQUIPMENT
22.19.1. BUSINESS OVERVIEW
22.19.2. PRODUCT OFFERINGS
22.20. MORETTI S.P.A.
22.20.1. BUSINESS OVERVIEW
22.20.2. PRODUCT OFFERINGS
22.21. NARANG MEDICAL
22.21.1. BUSINESS OVERVIEW
22.21.2. PRODUCT OFFERINGS
22.22. NEWMAN MEDICAL
22.22.1. BUSINESS OVERVIEW
22.22.2. PRODUCT OFFERINGS
22.23. PROMED TECHNOLOGY
22.23.1. BUSINESS OVERVIEW
22.23.2. PRODUCT OFFERINGS
22.24. PROMISE TECHNOLOGY
22.24.1. BUSINESS OVERVIEW
22.24.2. PRODUCT OFFERINGS
22.25. SHENZHEN AEON TECHNOLOGY
22.25.1. BUSINESS OVERVIEW
22.25.2. PRODUCT OFFERINGS
22.26. SHENZHEN BESTMAN INSTRUMENT
22.26.1. BUSINESS OVERVIEW
22.26.2. PRODUCT OFFERINGS
22.27. SHENZHEN LUCKCOME TECHNOLOGY
22.27.1. BUSINESS OVERVIEW
22.27.2. PRODUCT OFFERINGS
22.28. SHENZHEN UNICARE ELECTRONIC
22.28.1. BUSINESS OVERVIEW
22.28.2. PRODUCT OFFERINGS
22.29. SPENGLER HOLTEX GROUP
22.29.1. BUSINESS OVERVIEW
22.29.2. PRODUCT OFFERINGS
22.30. SURGITEK
22.30.1. BUSINESS OVERVIEW
22.30.2. PRODUCT OFFERINGS
22.31. TECHNOCARE MEDISYSTEMS
22.31.1. BUSINESS OVERVIEW
22.31.2. PRODUCT OFFERINGS
22.32. THE COOPER COMPANIES
22.32.1. BUSINESS OVERVIEW
22.32.2. PRODUCT OFFERING
22.33. TOITU
22.33.1. BUSINESS OVERVIEW
22.33.2. PRODUCT OFFERINGS
22.34. TRISMED
22.34.1. BUSINESS OVERVIEW
22.34.2. PRODUCT OFFERINGS
22.35. ULTRASOUND TECHNOLOGIES
22.35.1. BUSINESS OVERVIEW
22.35.2. PRODUCT OFFERINGS
22.36. YONKER
22.36.1. BUSINESS OVERVIEW
22.36.2. PRODUCT OFFERINGS
22.37. ZHENGZHOU DISON INSTRUMENT AND METER CO.
22.37.1. BUSINESS OVERVIEW
22.37.2. PRODUCT OFFERINGS
23. REPORT SUMMARY
23.1. KEY TAKEAWAYS
23.2. STRATEGIC RECOMMENDATIONS
24. QUANTITATIVE SUMMARY
24.1. MARKET BY PRODUCT TYPE
24.1.1. NORTH AMERICA
24.1.2. EUROPE
24.1.3. APAC
24.1.4. LATIN AMERICA
24.1.5. MIDDLE EAST & AFRICA
24.2. MARKET BY PORTABILITY
24.2.1. NORTH AMERICA
24.2.2. EUROPE
24.2.3. APAC
24.2.4. LATIN AMERICA
24.2.5. MIDDLE EAST & AFRICA
24.3. MARKET BY METHOD
24.3.1. NORTH AMERICA
24.3.2. EUROPE
24.3.3. APAC
24.3.4. LATIN AMERICA
24.3.5. MIDDLE EAST & AFRICA
24.4. MARKET BY APPLICATION
24.4.1. NORTH AMERICA
24.4.2. EUROPE
24.4.3. APAC
24.4.4. LATIN AMERICA
24.4.5. MIDDLE EAST & AFRICA
24.5. MARKET BY END-USER
24.5.1. NORTH AMERICA
24.5.2. EUROPE
24.5.3. APAC
24.5.4. LATIN AMERICA
24.5.5. MIDDLE EAST & AFRICA
24.6. MARKET BY GEOGRAPHY
24.7. PRODUCT TYPE
24.7.1. ULTRASOUND DEVICES
24.7.2. ELECTRONIC MATERNAL/FETAL MONITORS
24.7.3. FETAL ELECTRODES
24.7.4. FETAL DOPPLER
24.7.5. UTERINE CONTRACTION MONITORS
24.7.6. TELEMETRY DEVICES
24.7.7. OTHERS
24.8. PORTABILITY
24.8.1. PORTABLE
24.8.2. NON-PORTABLE
24.9. METHOD
24.9.1. NON-INVASIVE
24.9.2. INVASIVE
24.10. APPLICATION
24.10.1. ANTEPARTUM
24.10.2. INTRAPARTUM
24.11. END-USER
24.11.1. HOSPITALS
24.11.2. OBSTETRICS & GYNECOLOGY CLINICS
24.11.3. OTHERS
25. APPENDIX
25.1. RESEARCH METHODOLOGY
25.2. RESEARCH PROCESS
25.3. REPORT ASSUMPTIONS & CAVEATS
25.3.1. KEY CAVEATS
25.3.2. CURRENCY CONVERSION
26. ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings